期刊
EXPERT REVIEW OF NEUROTHERAPEUTICS
卷 11, 期 3, 页码 327-329出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERN.11.13
关键词
Alzheimer's disease; cholinesterase inhibitors; cost-effectiveness; National Institute for Clinical Excellence (UK)
分享论文
